Teleflex announces favorable results for UroLift™ in treating BPH, showing higher patient satisfaction and better early recovery compared to Rezūm. Teleflex Incorporated announced new results from the ...

New Delhi, Nov 09, 2022: Teleflex has announced the commercial launch of the UroLift System in India for treating benign prostatic hyperplasia (BPH), or enlarged prostate. The UroLift System is a ...

NeoTract, Inc., today announced the successful results of the 206-patient L.I.F.T. IDE Study, a multi-center, randomized, blinded study in patients with Benign Prostatic Hyperplasia (BPH). All primary ...

WAYNE, Pa., March 25, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that new findings from the CLEAR study were ...

The committee concluded that UroLift is clinically effective, with sustained relief of lower urinary tract symptoms up to 5 years after treatment. It is implanted using a minimally invasive procedure.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

WAYNE, Pa., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced that the U.S. Food and Drug Administration (FDA) has granted the company an expanded indication for the ...

Sponsored content: Enlarged prostate affects as many at 70 percent of men by the time they are in their 60s. Advanced Urology Associates offers a state of the art minimally invasive procedure called ...

As the population ages, the prevalence of Benign Prostatic Hyperplasia (BPH)—commonly known as an enlarged prostate—has increased significantly. Over 50% of men over 60 and 80% of those over 70 ...

PHOENIX, Jan. 31, 2018 /PRNewswire-PRWeb/ -- Affiliated Urologists today announced that Dr. Daniel Jaffee has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr.